The continued growth in US health care spending
1,2 and persistent suboptimal population health outcomes
3 have spurred increasing interest by payers to tie clinician reimbursement to quality and value
4 through alternative payment models (APMs). According to the Centers for Medicare & Medicaid Services (CMS), APMs provide financial incentives to encourage high-quality, cost-efficient care and can apply to a specific clinical condition, care episode, or population.
5 APMs are heterogeneous and can be divided into groups based on the type of payment (eg, fee-for-service or population-level) and category of financial risk to the clinician or health care organization (ie, none, penalties, bonuses, or both). Given the potential of these models to shift the focus of care from volume to value, APMs have been the subject of several initiatives on the federal, state, and payer levels since the passage of the Patient Protection and Affordable Care Act in 2010.
6-8